(Q30394396)

English

Cross-clade protection against HPAI H5N1 influenza virus challenge in BALB/c mice intranasally administered adjuvant-combined influenza vaccine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Cross-clade protection against HPAI H5N1 influenza virus challenge in BALB/c mice intranasally administered adjuvant-combined influenza vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

influenza vaccine

1 reference

based on heuristic

inferred from title

author name string

Penghui Yang

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Chong Tang

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Deyan Luo

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Zhongpeng Zhan

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Li Xing

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Yueqiang Duan

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Weihong Jia

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Daxin Peng

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Xiufan Liu

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Xiliang Wang

10

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

publication date

31 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Veterinary Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

146

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

17-23

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Poly (I:C) induced immune response in lymphoid tissues involves three sequential waves of type I IFN expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Pandemic H5N1 influenza vaccine development: an update.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Current status and progress of prepandemic and pandemic influenza vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Emergence and pandemic potential of swine-origin H1N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Strategies of immunization against mucosal infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Safety of MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Emulsion-based adjuvants for influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2010.03.024

7 January 2021

Identifiers

10.1016/J.VETMIC.2010.03.024

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30394396&oldid=1646379380"